Fang Fěng

4.9k total citations · 1 hit paper
170 papers, 3.8k citations indexed

About

Fang Fěng is a scholar working on Molecular Biology, Plant Science and Oncology. According to data from OpenAlex, Fang Fěng has authored 170 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 28 papers in Plant Science and 25 papers in Oncology. Recurrent topics in Fang Fěng's work include Traditional Chinese Medicine Analysis (22 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Analytical Chemistry and Chromatography (13 papers). Fang Fěng is often cited by papers focused on Traditional Chinese Medicine Analysis (22 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Analytical Chemistry and Chromatography (13 papers). Fang Fěng collaborates with scholars based in China, United States and Taiwan. Fang Fěng's co-authors include Lian‐Yue Yang, Ruimin Chang, Qing Wang, Fan Wu, Keao Hu, Caixing Sun, Liang Xia, Gongjun Yang, Hang Wang and Ming Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and The Science of The Total Environment.

In The Last Decade

Fang Fěng

163 papers receiving 3.8k citations

Hit Papers

Humic Acid Fertilizer Imp... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Fěng China 35 1.7k 608 510 417 289 170 3.8k
Chien‐Chih Chiu Taiwan 41 2.8k 1.7× 806 1.3× 321 0.6× 563 1.4× 284 1.0× 199 5.2k
Haitao Zhang China 39 2.4k 1.4× 279 0.5× 981 1.9× 270 0.6× 145 0.5× 201 6.6k
Jian‐Ping Yuan China 35 1.6k 0.9× 265 0.4× 434 0.9× 525 1.3× 355 1.2× 89 5.3k
Le Zhang China 37 2.2k 1.3× 1.1k 1.8× 195 0.4× 207 0.5× 185 0.6× 167 4.4k
Pengfei Wang China 40 1.7k 1.0× 454 0.7× 232 0.5× 924 2.2× 307 1.1× 302 5.8k
Metka Filipič Slovenia 43 1.1k 0.7× 760 1.3× 513 1.0× 157 0.4× 444 1.5× 126 5.7k
Chao Liu China 42 3.6k 2.2× 2.0k 3.3× 835 1.6× 752 1.8× 482 1.7× 357 7.2k
Yifan Li China 30 1.3k 0.8× 514 0.8× 150 0.3× 243 0.6× 360 1.2× 156 3.1k
Yixuan Zhang China 34 1.6k 0.9× 353 0.6× 178 0.3× 404 1.0× 205 0.7× 169 3.8k
Leilei Zhang China 35 1.5k 0.9× 318 0.5× 703 1.4× 197 0.5× 393 1.4× 219 4.4k

Countries citing papers authored by Fang Fěng

Since Specialization
Citations

This map shows the geographic impact of Fang Fěng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Fěng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Fěng more than expected).

Fields of papers citing papers by Fang Fěng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Fěng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Fěng. The network helps show where Fang Fěng may publish in the future.

Co-authorship network of co-authors of Fang Fěng

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Fěng. A scholar is included among the top collaborators of Fang Fěng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Fěng. Fang Fěng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Peiran, Gege Huang, Zilan Song, et al.. (2024). Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas. Acta Pharmacologica Sinica. 45(10). 2163–2173. 2 indexed citations
4.
Ren, Shaohua, Guangtao Li, Fang Fěng, et al.. (2022). Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study. SHILAP Revista de lepidopterología. Volume 9. 799–810. 9 indexed citations
6.
Chen, Suyun, Kejun He, Fang Fěng, et al.. (2019). Metabolic tumor burden on baseline 18F-FDG PET/CT improves risk stratification in pediatric patients with mature B-cell lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 46(9). 1830–1839. 18 indexed citations
7.
Zhang, Tao, Shiliang Li, Linjiang Tong, et al.. (2019). Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFRL858R/T790M/C797S. ACS Medicinal Chemistry Letters. 10(6). 869–873. 52 indexed citations
8.
Chen, Lu, Yuchao He, Ziye Chen, et al.. (2018). HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death and Disease. 9(5). 513–513. 192 indexed citations
10.
Fěng, Fang. (2012). Construction of RNAi Expression Vector of MsZIP Gene from Medicago sativa L. and Genetic Transformation in Alfalfa. Zhongguo caodi xuebao. 1 indexed citations
11.
Fěng, Fang. (2012). Effect of Different Formula Compatibility of Zhi-Zi-Hou-Pu Decoction on the Intestinal Absorption of Geniposide. 1 indexed citations
12.
Fěng, Fang. (2011). Effect of different formula compatibility of Zhizi Houpu decoction on the pharmacokinetics of naringenin and hesperetin. Zhongguo yaoke daxue xuebao. 3 indexed citations
13.
Fěng, Fang. (2011). HPLC determination of scutellarin and its related substances in breviscapine injection. Yaowu fenxi zazhi. 1 indexed citations
14.
Fěng, Fang, et al.. (2009). LC-PDA-MS/MS analysis and anti-depressant study of Zhizi-Gancao-Chi decoction.. Zhongguo yaoke daxue xuebao. 40(4). 342–347. 1 indexed citations
15.
Fěng, Fang, et al.. (2009). Analysis of the characteristic ingredients in Zhi-Zi-Hou-Pu decoction and dissolution of these compounds in different compatibility using various hyphenated chromatographic-spectrum techniques. Zhongguo yaoke daxue xuebao. 40(5). 426–430. 1 indexed citations
16.
Fěng, Fang. (2008). Study on Pharmacokinetic Interaction of Ondansetron and Chlorpromazine in Rat. Zhōnghuá yàoxué zázhì. 1 indexed citations
17.
Fěng, Fang. (2008). HPLC-MS assay for the determination of bromhexine in human plasma and application to bioequivalence studies. 1 indexed citations
18.
Fěng, Fang. (2006). Evaluation of HPLC-fluorescence and LC-ESI/MS for determination of telmisartan in human plasma. Yaowu fenxi zazhi. 3 indexed citations
19.
Fěng, Fang. (2006). Determination of Sertraline in Human Plasma by LC-MS: Application to Relative Bioavailability of Domestic and Imported Sertraline Tablets. Zhōnghuá yàoxué zázhì. 1 indexed citations
20.
Fěng, Fang. (2003). Determination of Seratrodast in Human Plasma by HPLC. Chinese Journal of Pharmaceuticals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026